Prominent health-equity advocate named editor of JAMA; ransomware attacks cause crises at rural hospitals

The American Medical Association has appointed a prominent health-equity researcher as JAMA's new editor-in-chief.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

After accusations of structural racism at JAMA, a Black health-equity advocate is named the journal's editor By Usha Lee McFarling Courtesy Kirsten Bibbins-Domingo The AMA appointed a Black health-equity researcher as JAMA editor-in-chief — the first woman of color to lead the prestigious publication. Read More At small and rural hospitals, ransomware attacks are causing unprecedented crises By Marion Renault Mike Reddy for STAT Cybercriminals are bombarding the entire U.S. health system. Small and rural providers are particularly vulnerable. Read More STAT+: Giving immunotherapy before surgery prevents lung cancer from returning, study says By Matthew Herper AP/Business Wire A new study finds benefits to giving an immunotherapy made by Bristol-Myers Squibb to lung cancer patients before surgery. Read More Sponsor content by STAT Events Battle scars: The journey from lab to patient's bedside Join STAT on May 3 in Boston to explore the challenges, and the unique opportunities for new approaches, solutions, and partnerships, of the drug development process. This in-person program will bring together a diverse group of individuals to share their perspectives about the drug development process. Stay once the conversation is complete for a networking and cocktail reception with STAT and your fellow attendees. Get your ticket now (and save 40% as a STAT+ subscriber). Opinion: The 'successful failures' of Apollo 13 and Covid-19 vaccination By Christopher M. Worsham and Anupam B. Jena AP Apollo 13 astronaut James Lovell called the mission a "successful failure." That term can apply to the U.S.'s Covid-19 vaccination effort. Read More STAT+: Private equity giant Carlyle to acquire biotech venture capital firm Abingworth By Kate Sheridan Adobe The Carlyle Group will acquire Abingworth, one of biotech’s oldest life sciences venture capital groups, it announced Monday. Read More Monday, April 11, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser